Recently approved recombinant factor VIII (rFVIII) for the replacement treatment in patients with hemophilia A in Italy. FE [Internet]. 2017 Oct. 6 [cited 2025 Dec. 29];18(1). Available from: https://journals.seedstm.com/index.php/FE/article/view/1321